MedPath

CONSI-BOSAN B51 - LIQ.

CONSI-BOSAN B51 - LIQ.

Discontinued
DIN Number

02151391

Drug Class

Human

Market Date

Dec 31, 1996

Company
HC

professional health products

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02151391
AIG Number0327318001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (3)

HYDRASTIS CANADENSISActive
Strength: 4 D / ML
Monograph: HYDRASTIS CANADENSIS
LYCOPODIUMActive
Strength: 3 D / ML
Monograph: LYCOPODIUM
SODIUM SULFATEActive
Strength: 4 D / ML
Monograph: SODIUM SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.